ARCHIVES

ASCO Draft Recommendations Define Meaningful Trial Outcomes

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

NCAB Plans Study Of Its Authorities. FDA, NIH To Provide $6.75 Million For Grants In Regulatory Science

February 26, 2010

Yates Identifies “Probable”, “Potential” Core Grant Applicants

January 16, 1987

Three researchers share Paul Marks Prize.

November 11, 2005

Toxic Substance Act Would Affect Cancer Program

March 21, 1975

In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online

February 5, 1999

Centers Urged To Apply For Comprehensive Status By June 1

February 16, 1990